Clinical Trial Detail

NCT ID NCT03838367
Title Leronlimab (PRO 140) Combined With Carboplatin in Patients With CCR5+ mTNBC
Recruitment Recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors CytoDyn, Inc.
Indications

triple-receptor negative breast cancer

Therapies

Carboplatin + Leronlimab

Age Groups: senior adult

No variant requirements are available.